Deferoxamine mesylate (CAT: I001474) is a chelating agent primarily used to remove excess iron from the body. It forms a complex with iron, which can then be excreted in the urine. Deferoxamine mesylate is commonly used in the treatment of acute iron poisoning, particularly in young children who have ingested iron-containing substances. It is also employed in the management of conditions such as hemochromatosis, which can be either inherited or acquired and is characterized by excess iron accumulation in the body. By binding to iron, deferoxamine mesylate helps reduce iron overload and its associated complications.
| Catalog Number | I001474 |
| CAS Number | 138-14-7 |
| Synonyms | Ba 33112;DFOM;DFX;NSC 644468 |
| Molecular Formula | C25H48N6O8 • CH3SO3H |
| Purity | ≥95% |
| Solubility | H2O: ≥ 33 mg/mL |
| Storage | -20°C |
| InChIKey | IDDIJAWJANBQLJ-UHFFFAOYSA-N |
| Reference | <p style=/line-height:25px/> |
